• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic buys Dutch diabetes clinic

Medtronic buys Dutch diabetes clinic

April 2, 2015 By Brad Perriello

Medtronic buys Dutch diabetes clinic

Medtronic (NYSE:MDT) said today that it made its 1st foray into integrated care for diabetics, acquiring a Dutch diabetes clinic and research center called Diabeter for an undisclosed amount.

Diabeter provides care for more than 1,500 children and young adults with Type I diabetes, using technologies developed at the clinic to help patients manage their disease. Medtronic said internal data show that the Diabeter approach allows patients to maintain their blood glucose levels at near-normal levels, an important factor in reducing the long-term complications (and costs) of the disease.

"The Diabeter acquisition is a milestone for Medtronic and for the diabetes group," diabetes group president Hooman Hakami said in prepared remarks. "This acquisition marks Medtronic’s 1st entry into a diabetes integrated care model approach and signifies that Medtronic Diabetes is more than pumps and sensors – we are a holistic diabetes management company focused on making a real difference in outcomes and cost."

Diabeter will operate under Medtronic’s diabetes services & solutions umbrella, but retain its "professional autonomy" in making clinical decisions and choosing medical device brands, Medtronic said.

Dr. Henk Veeze, senior international medical director of the center, said the care model developed at Diabeter can be extended around the world.

"Diabeter has been pioneering this type of integrated care in the Netherlands, and we believe this approach can be applied more broadly to serve more patients, in more places around the world," Veeze said. "We have developed a unique system with improved clinical outcomes, combining outstanding clinical care with devices and information technology."

"Diabeter and Medtronic share the same goal of transforming diabetes care for greater freedom and better health. By joining forces, Diabeter and Medtronic can further advance the development of technology and integrated care models that improve clinical and economical outcomes for people with diabetes and for the healthcare system," added diabetes services & solutions general manager Annette Brüls. "We aim to accelerate access to this new model of diabetes care in the Netherlands and beyond."

Filed Under: Diabetes, Mergers & Acquisitions, News Well Tagged With: Diabeter

More recent news

  • Massachusetts Life Sciences Center offers grants to lower medtech commercial risk
  • The 10 largest medical device companies
  • CSL to drop Terumo for Haemonetics in US plasma collection supply deal
  • How 5 medtech CEOs design for access
  • Butterfly Network to chase ultrasound brain-computer interfaces with newcomer Bridge Neurotech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy